Joe W. Gray, Ph.D.

  • Professor of Biomedical Engineering, School of Medicine
  • Gordon Moore Endowed Chair, Biomedical Engineering, School of Medicine
  • Associate Director for Biophysical Oncology, OHSU Knight Cancer Institute, School of Medicine
  • Director, OHSU Center for Spatial Systems Biomedicine, School of Medicine
  • Program in Molecular and Cellular Biosciences, School of Medicine
  • Cancer Biology Graduate Program, School of Medicine


Dr. Joe W. Gray, a physicist and an engineer by training, holds positions as Professor and Gordon Moore Endowed Chair, Biomedical Engineering Department; Director, OHSU Center for Spatial Systems Biomedicine (OCSSB); and Associate Director for Biophysical Oncology, Knight Cancer Institute at the Oregon Health & Science University. He is also Emeritus Professor, University of California, San Francisco; and Senior Scientist, Lawrence Berkeley National Laboratory.

He was a Staff Scientist in the Biomedical Sciences Division of the Lawrence Livermore National Laboratory (1972-1991), Professor of Laboratory Medicine at the University of California, San Francisco (1991-2011), and Associate Laboratory Director for Biosciences and Life Sciences Division Director at the Lawrence Berkeley National Laboratory (2003-2011).

He is PI of the NCI/Research Center for Cancer Systems Biology Consortium (CSBC), "Measuring, Modeling and Controlling Heterogeneity" (M2CH) that is aimed at developing a systems level understanding of how intrinsic and extrinsic factors work together to enable triple-negative breast cancer to escape therapeutic control in order to devise robust control strategies; PI of an NIH program to contribute to further development of the NIH Library of Integrated Network-based Cellular Signatures program (LINCS) and to develop a dataset and computational strategy to elucidate how microenvironmental signals affect cell intrinsic intracellular transcriptional- and protein-defined molecular networks to generate experimentally durable therapies for patients; PI of an NCI Human Tumor Atlas Network Research center that performs comparative omic and multiscale image analyses of responsive and resistant metastatic breast lesions within individual patients to discover mechanisms of resistance so they can be attacked therapeutically; co-director of the "Serial Measurement of Molecular and Architectural Responses to Therapy" (SMMART) clinical trials program that aims to provide a transformative approach to cancer treatment that focuses on each person who faces cancer to create more effective, durable therapies for treatment of prostate cancer, pancreatic cancer and leukemia; PI of a Brenden-Colson Center for Pancreatic Care project that provides support for a broad-based, team approach to finding causes, early detection and improvement of clinical care for pancreatic diseases including pancreatitis and pancreatic cancer; and PI of a Susan G. Komen project to identify the mechanisms by which ERBB2+ breast cancer cells escape inhibition by ERRB2-targeted therapies.

Dr. Gray's work is described in over 500 publications and 80 US patents. He is a Fellow of the American Association for the Advancement of Science and the American Institute for Medical and Biological Engineering; an elected a member of the Institute of Medicine of the National Academy of Sciences; a member of the National Institutes of Health; a Fellow of the American Association of Cancer Research Academy; and Executive Councilor of the Board of Councilors for the Radiation Effects Research Foundation (RERF), Hiroshima, Japan.


  • Professional Engineer, 1968, Colorado School of Mines
  • Ph.D., 1972, Kansas State University

Memberships and associations

  • American Association for Cancer Research
  • American Association for the Advancement of Science
  • American Society for Human Genetics
  • Human Genome Organization
  • International Society for Analytical Cytology
  • Radiation Research Society



  • {{ pub.journalAssociation.journal.names[0].value }}